Literature DB >> 27088854

A splicing switch from ketohexokinase-C to ketohexokinase-A drives hepatocellular carcinoma formation.

Xinjian Li1, Xu Qian1, Li-Xia Peng2, Yuhui Jiang1,3, David H Hawke4, Yanhua Zheng1, Yan Xia1, Jong-Ho Lee1, Gilbert Cote5, Hongxia Wang3, Liwei Wang3, Chao-Nan Qian2, Zhimin Lu1,6,7.   

Abstract

Dietary fructose is primarily metabolized in the liver. Here we demonstrate that, compared with normal hepatocytes, hepatocellular carcinoma (HCC) cells markedly reduce the rate of fructose metabolism and the level of reactive oxygen species, as a result of a c-Myc-dependent and heterogeneous nuclear ribonucleoprotein (hnRNP) H1- and H2-mediated switch from expression of the high-activity fructokinase (KHK)-C to the low-activity KHK-A isoform. Importantly, KHK-A acts as a protein kinase, phosphorylating and activating phosphoribosyl pyrophosphate synthetase 1 (PRPS1) to promote pentose phosphate pathway-dependent de novo nucleic acid synthesis and HCC formation. Furthermore, c-Myc, hnRNPH1/2 and KHK-A expression levels and PRPS1 Thr225 phosphorylation levels correlate with each other in HCC specimens and are associated with poor prognosis for HCC. These findings reveal a pivotal mechanism underlying the distinct fructose metabolism between HCC cells and normal hepatocytes and highlight the instrumental role of KHK-A protein kinase activity in promoting de novo nucleic acid synthesis and HCC development.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27088854      PMCID: PMC4888794          DOI: 10.1038/ncb3338

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  36 in total

1.  Steady state kinetic model for the binding of substrates and allosteric effectors to Escherichia coli phosphoribosyl-diphosphate synthase.

Authors:  M Willemoës; B Hove-Jensen; S Larsen
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

2.  Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray.

Authors:  Yi Wang; Meng-Chao Wu; Jonathan S T Sham; Weigou Zhang; Wei-Qing Wu; Xin-Yuan Guan
Journal:  Cancer       Date:  2002-12-01       Impact factor: 6.860

3.  Mutation in the phosphoribosylpyrophosphate synthetase gene (prs) that results in simultaneous requirements for purine and pyrimidine nucleosides, nicotinamide nucleotide, histidine, and tryptophan in Escherichia coli.

Authors:  B Hove-Jensen
Journal:  J Bacteriol       Date:  1988-03       Impact factor: 3.490

4.  Structural basis for the function of Bacillus subtilis phosphoribosyl-pyrophosphate synthetase.

Authors:  T A Eriksen; A Kadziola; A K Bentsen; K W Harlow; S Larsen
Journal:  Nat Struct Biol       Date:  2000-04

5.  The RNA lariat: a new ring to the splicing of mRNA precursors.

Authors:  W Keller
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

6.  Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL.

Authors:  Benshang Li; Hui Li; Yun Bai; Renate Kirschner-Schwabe; Jun J Yang; Yao Chen; Gang Lu; Gannie Tzoneva; Xiaotu Ma; Tongmin Wu; Wenjing Li; Haisong Lu; Lixia Ding; Huanhuan Liang; Xiaohang Huang; Minjun Yang; Lei Jin; Hui Kang; Shuting Chen; Alicia Du; Shuhong Shen; Jianping Ding; Hongzhuan Chen; Jing Chen; Arend von Stackelberg; Longjun Gu; Jinghui Zhang; Adolfo Ferrando; Jingyan Tang; Shengyue Wang; Bin-Bing S Zhou
Journal:  Nat Med       Date:  2015-05-11       Impact factor: 53.440

7.  Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria.

Authors:  Aruna Asipu; Bruce E Hayward; John O'Reilly; David T Bonthron
Journal:  Diabetes       Date:  2003-09       Impact factor: 9.461

8.  Overexpression, purification, and characterization of recombinant human 5-phosphoribosyl-1-pyrophosphate synthetase isozymes I and II.

Authors:  J M Nosal; R L Switzer; M A Becker
Journal:  J Biol Chem       Date:  1993-05-15       Impact factor: 5.157

9.  Reaction of monosaccharides with proteins: possible evolutionary significance.

Authors:  H F Bunn; P J Higgins
Journal:  Science       Date:  1981-07-10       Impact factor: 47.728

10.  HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease.

Authors:  Peter Mirtschink; Jaya Krishnan; Fiona Grimm; Alexandre Sarre; Manuel Hörl; Melis Kayikci; Niklaus Fankhauser; Yann Christinat; Cédric Cortijo; Owen Feehan; Ana Vukolic; Samuel Sossalla; Sebastian N Stehr; Jernej Ule; Nicola Zamboni; Thierry Pedrazzini; Wilhelm Krek
Journal:  Nature       Date:  2015-06-17       Impact factor: 49.962

View more
  65 in total

Review 1.  Intersections of post-transcriptional gene regulatory mechanisms with intermediary metabolism.

Authors:  Waqar Arif; Gandhar Datar; Auinash Kalsotra
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-11       Impact factor: 4.490

Review 2.  Splicing alterations contributing to cancer hallmarks in the liver: central role of dedifferentiation and genome instability.

Authors:  Maddalen Jimenez; María Arechederra; Matías A Ávila; Carmen Berasain
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-31

3.  Genome-Wide CRISPR Screen for Essential Cell Growth Mediators in Mutant KRAS Colorectal Cancers.

Authors:  Edwin H Yau; Indrasena Reddy Kummetha; Gianluigi Lichinchi; Rachel Tang; Yunlin Zhang; Tariq M Rana
Journal:  Cancer Res       Date:  2017-09-27       Impact factor: 12.701

Review 4.  The role of RNA alternative splicing in regulating cancer metabolism.

Authors:  Itamar Kozlovski; Zahava Siegfried; Adi Amar-Schwartz; Rotem Karni
Journal:  Hum Genet       Date:  2017-04-20       Impact factor: 4.132

5.  Fructokinase A acts as a protein kinase to promote nucleotide synthesis.

Authors:  Xinjian Li; Xu Qian; Zhimin Lu
Journal:  Cell Cycle       Date:  2016-06-29       Impact factor: 4.534

6.  Corrigendum: A splicing switch from ketohexokinase-C to ketohexokinase-A drives hepatocellular carcinoma formation.

Authors:  Xinjian Li; Xu Qian; Li-Xia Peng; Yuhui Jiang; David H Hawke; Yanhua Zheng; Yan Xia; Jong-Ho Lee; Gilbert Cote; Hongxia Wang; Liwei Wang; Chao-Nan Qian; Zhimin Lu
Journal:  Nat Cell Biol       Date:  2016-05-27       Impact factor: 28.824

7.  HNRNPH1 is required for rhabdomyosarcoma cell growth and survival.

Authors:  Yanfeng Li; Jesse Bakke; David Finkelstein; Hu Zeng; Jing Wu; Taosheng Chen
Journal:  Oncogenesis       Date:  2018-01-24       Impact factor: 7.485

Review 8.  Metabolic Kinases Moonlighting as Protein Kinases.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Trends Biochem Sci       Date:  2018-02-17       Impact factor: 13.807

9.  Deletion of Fructokinase in the Liver or in the Intestine Reveals Differential Effects on Sugar-Induced Metabolic Dysfunction.

Authors:  Ana Andres-Hernando; David J Orlicky; Masanari Kuwabara; Takuji Ishimoto; Takahiko Nakagawa; Richard J Johnson; Miguel A Lanaspa
Journal:  Cell Metab       Date:  2020-06-04       Impact factor: 27.287

Review 10.  Proteins moonlighting in tumor metabolism and epigenetics.

Authors:  Lei Lv; Qunying Lei
Journal:  Front Med       Date:  2021-01-02       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.